resistance mechanisms to flt3 inhibitors in aml
Published 6 years ago • 134 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
2:59
using a genome-wide crispr screen to evaluate mechanisms of resistance to flt3 inhibitors in aml
-
2:55
the importance of flt3 inhibitors in aml and factors to consider when choosing between these agents
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
2:57
investigating mechanisms of resistance to immunotherapy in aml: the role of tp53 aberrations
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
2:40
an overview of the safety profile of flt3 inhibitors in aml
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
16:13
3mensio ct pre-case planning: valve-in-valve tavr in trifecta
-
14:21
3mensio ct pre-case planning: valve-in-valve tavr in mosaic
-
3:27
novel flt3 inhibitors for aml
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
2:29
flt3 inhibitors as maintenance therapy in aml
-
8:36
flt3 mutational status can change between diagnosis and relapse in patients with aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
1:30
combinations with flt3 inhibitors: the way forward for aml treatment
-
2:30
flt3 inhibitors - their role in aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:12
flt3 inhibitors in the treatment of aml